205 related articles for article (PubMed ID: 31257076)
1. Use of calcium channel blockers and myocardial infarction in hypertensive patients with rheumatoid arthritis - A nationwide cohort study.
Lin TT; Ko TY; Lin LY; Wu CK
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):350-358. PubMed ID: 31257076
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.
Lin TT; Wu CK; Liao MT; Yang YH; Chen PC; Yeih DF; Lin LY
PLoS One; 2017; 12(12):e0188720. PubMed ID: 29216228
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ
Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103
[TBL] [Abstract][Full Text] [Related]
4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction-A Nationwide Cohort Study.
Liu SF; Lee CK; Huang KC; Lin LY; Hsieh MY; Lin TT
Front Pharmacol; 2021; 12():726044. PubMed ID: 34621167
[No Abstract] [Full Text] [Related]
6. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Jeffers BW; Robbins J; Bhambri R
Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
[TBL] [Abstract][Full Text] [Related]
7. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
[TBL] [Abstract][Full Text] [Related]
8. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
10. Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study.
Durán J; Peloquin C; Zhang Y; Felson DT
J Rheumatol; 2017 Apr; 44(4):418-424. PubMed ID: 28250138
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers and myocardial infarction: a case--control study in a Japanese hospital.
Ohyama Y; Funao K; Kawabe E; Hayashi D; Yamazaki T; Iga T; Koide D; Ohe K; Kubota K
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):487-92. PubMed ID: 12426933
[TBL] [Abstract][Full Text] [Related]
12. Use of Calcium Channel Blockers and Risk of Active Tuberculosis Disease: A Population-Based Analysis.
Lee CC; Lee MG; Hsu WT; Park JY; Porta L; Liu MA; Chen SC; Chang SC
Hypertension; 2021 Feb; 77(2):328-337. PubMed ID: 33307850
[TBL] [Abstract][Full Text] [Related]
13. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
[No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis and risk of acute myocardial infarction--a nationwide retrospective cohort study.
Chung WS; Lin CL; Peng CL; Chen YF; Lu CC; Sung FC; Kao CH
Int J Cardiol; 2013 Oct; 168(5):4750-4. PubMed ID: 23938220
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers in cardiovascular pharmacotherapy.
Godfraind T
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
Lee YC; Lin CH; Wu RM; Lin JW; Chang CH; Lai MS
PLoS One; 2014; 9(6):e98961. PubMed ID: 24910980
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
18. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
19. Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics.
Anderson RJ; Alabi RA; Kelly WN; Diseker R; Roblin D
J Manag Care Pharm; 2003; 9(1):29-35. PubMed ID: 14613359
[TBL] [Abstract][Full Text] [Related]
20. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
